Last reviewed · How we verify

NCT01824706: CUSTOMBONE

Prospective, Multicenter Observational Study Evaluating the Long Term Safety of the Custombone Implant

Completed Last updated 2 July 2018
What this trial tests

trial testing craniectomy in Surgery in 110 participants. Completed in 1 May 2016.

Timeline
1 December 2012
Primary endpoint
1 May 2016
1 May 2016

Quick facts

Lead sponsorIntegra LifeSciences Corporation
StatusCompleted
Study typeOBSERVATIONAL
Enrollment110
Start date1 December 2012
Primary completion1 May 2016
Estimated completion1 May 2016
Sites18 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Integra LifeSciences Corporation — full company profile →

Who can join

Eligibility, any sex, with Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Prospective, Multicenter Observational Study Evaluating the Long Term Safety in Terms of Explantation Rate and Number of Infections of the Custom-made Bioceramic Implant CustomBone™ The patients will be included as soon as they are implanted and follow-up for 2 years. It is observational so no specific exam is planned. The explantation rate will be measured, that is to say the number of patients whose prosthesis will be removed (with or without any relationship with the implant or the procedure).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of craniectomy

Trials testing the same drug.

Other recruiting trials for Surgery

Currently open trials in the same condition.

Other Integra LifeSciences Corporation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01824706.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing